Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-05

Clinical Trial Update: Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the sensitivity and specificity of the prick test to Betula verrucosa (birch pollen).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prick Test Betula Verrucosa

Snippet

Sponsor: Inmunotek S.L. | Conditions: Immune System Diseases | Phase 2 | Status: COMPLETED | Results posted: 2022-05-05